Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-27

Clinical Trial Update: Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the safety and efficacy of insulin detemir in combination with oral antidiabetic drugs in patients with type 2 diabetes; the study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED